Rainbow Children's Medicare Limited
Rainbow Children's Medicare Limited operates a multi-specialty paediatric, obstetrics, and gynaecology hospital chain in India. The company offers medical and healthcare services to children and women. It also provides pediatric services under brand Rainbow Children's Hospital which include newborn and pediatric intensive care; pediatric multi-specialty services; and pediatric quaternary care, such as multi-organ transplantation. In addition, the company offers women care services under Birthright brand that comprise perinatal care services, such as routine and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility support, and a range of gynecology treatments, as well as operates private pediatric DNB (Diplomate of National Board) training program offering postgraduate and fellowship opportunities to train future healthcare professionals. Rainbow Children's Medicare Limited was incorporated in 1998 and is based in Hyderabad, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Strong 5-year net profit CAGR of 24.8%
Concerns1
- Operating margin declining for 3 consecutive years (35.0% β 34.0% β 33.0%)
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ1.46 K Cr | β | βΉ238.00 Cr | β | β | 16.0% | 17.6% | 10.7% |
| Mar 2024 | βΉ1.24 K Cr | β | βΉ215.00 Cr | β | β | 16.7% | 11.0% | 4.4% |
| Mar 2023 | βΉ1.11 K Cr | β | βΉ206.00 Cr | β | β | 18.9% | 20.4% | 45.1% |
| Mar 2022 | βΉ925.00 Cr | β | βΉ142.00 Cr | β | β | 22.7% | 50.7% | 189.8% |
| Mar 2021 | βΉ614.00 Cr | β | βΉ49.00 Cr | β | β | 10.5% | -11.7% | -31.0% |
| Mar 2020 | βΉ695.00 Cr | β | βΉ71.00 Cr | β | β | 17.1% | 28.0% | 18.3% |
| Mar 2019 | βΉ543.00 Cr | β | βΉ60.00 Cr | β | β | 14.9% | 35.1% | 66.7% |
| Mar 2018 | βΉ402.00 Cr | β | βΉ36.00 Cr | β | β | 10.3% | 71.8% | 111.8% |
| Mar 2016 | βΉ234.00 Cr | β | βΉ17.00 Cr | β | β | 6.0% | 58.1% | -37.0% |
| Mar 2015 | βΉ148.00 Cr | β | βΉ27.00 Cr | β | β | 15.1% | β | β |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 1,479 |
| Total Expenses | 998 |
| EBIT / Operating Profit | 481 |
| OPM % | 33% |
| Other Income | 54 |
| Finance Costs | 69 |
| Depreciation & Amortisation | 132 |
| Profit Before Tax | 334 |
| Tax % | - |
| Net Profit / PAT | 246 |
| EPS (βΉ) | 24.26 |
| Dividend Payout % | - |
Peer Comparison
Healthcare sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Rainbow Children's Medicare Limitedthis co. | βΉ12.76 K Cr | βΉ1.46 K Cr | 51.80 | 8.06 | 29.47 | 17.6% |
| Sun Pharmaceutical Industries Ltd. | βΉ4.15 L Cr | βΉ23.00 K Cr | 88.70 | 17.43 | 72.30 | 13.5% |
| Divi's Laboratories Ltd. | βΉ1.71 L Cr | βΉ9.20 K Cr | 67.90 | 11.13 | 67.21 | 20.0% |
| Torrent Pharmaceuticals Ltd. | βΉ1.33 L Cr | βΉ9.68 K Cr | 62.50 | 15.76 | 45.64 | 13.5% |
| Cipla Ltd. | βΉ1.17 L Cr | βΉ19.05 K Cr | 22.50 | 3.51 | 19.33 | 14.9% |
| Apollo Hospitals Enterprises Ltd. | βΉ1.05 L Cr | βΉ8.20 K Cr | 75.00 | 11.28 | 54.44 | 12.8% |
| Max Healthcare Institute Limited | βΉ1.00 L Cr | βΉ2.66 K Cr | 144.00 | 11.76 | 96.84 | 13.8% |
| Industry Average | β | βΉ3.29 K Cr | 98.63 | 8.11 | 65.50 | 20.2% |